By measuring tumor volumes and quantifying CTC abundance of tumor‐bearing mice treated with insulin and glucose, respectively (daily for 1 week during the rest phase), the authors found that daily oscillations of crucial circadian regulatory hormones can affect the proliferation and intravasation of breast cancer cells due to overexpression of their receptors. This evidence concerns the gene INS and neoplasm.